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A Message from Chancellor Roth

Dear Colleagues:
The United States now has more than 150,000 recorded cases of the novel coronavirus. Here
in New Mexico, 237 people have tested positive for the novel coronavirus, and more
than 11,000 tests have been administered statewide. Please visit the New Mexico Department
of Health website for the latest updates.
The rapid increase in the number of new cases underscores the terrible burden this pandemic
is placing on our health care workers. Today – National Doctors’ Day – I want to salute the men
and women who have devoted their careers to serving the community’s health needs, often at
great personal cost.
Now, when the need for their services is greater than ever, their selflessness and
professionalism serve as an inspiration to us all.
I’m pleased to report that we are joining in two newly launched clinical trials of medications that
could potentially serve as treatments for COVID-19 infection. One drug – an antiviral called
remdesivir – will be tested in patients who have both the infection and pneumonia symptoms.
The other, an antimalarial drug called hydroxychloroquine, will be combined with an antibiotic
called azithromycin as a possible treatment for patients who test positive for the virus but lack
pneumonia symptoms.
The research into these drugs is part of an urgent national research initiative to find a way to
treat this disease. I’m cautiously optimistic about their therapeutic potential.

Finally, in the face of the all the negative news we’ve had to cope with lately, I think it’s worth
remembering that the human spirit is capable of great resilience in the face of adversity – and
that’s a message I would like to accentuate.
Toward that end, I want to encourage you to share with me – and the HSC community –
instances in which you or your coworkers have gone above and beyond the call of duty in
meeting the challenges we are facing. I think we all could use a little encouragement in these
troubled times.
Warm regards,

Paul B. Roth, MD, MS
Chancellor for Health Sciences
CEO, UNM Health System
Dean, UNM School of Medicine

